Juno Therapeutics Enters Battle Over CAR Cancer Immunotherapy Technology

University of Pennsylvania seeks court order that its cancer immunotherapy does not infringe St. Jude’s patent; Juno, which licensed the patent for the potential leukemia treatment, has joined the settlement talks.